Taysha Gene Therapies completed patient dosing in two of its key Rett syndrome trials, marking critical progress toward a potential new gene therapy. With second quarter 2026 financial results reinforcing its commitment, the company aims to share top-line data and pursue FDA milestones in the year ahead.

In an opinion piece titled “Ozempic made me question everything I believed about hunger,” the author explores how beliefs about appetite can evolve. Although the article’s full text is behind a paywall, references to the FDA suggest that the discussion extends beyond personal reflection.

A newly approved weight-loss drug, Foundayo (orforglipron), has arrived months ahead of schedule after gaining FDA clearance in just 50 days. The swift approval signals a growing momentum in the development of anti-obesity treatments.